About
Biocaptiva Ltd develops patented polymer technology called msX™ for direct capture of circulating cell-free DNA (cfDNA) from biological fluids, enabling improved liquid biopsy sample quality and stability for non-invasive genetic testing and personalized medicine.
Explore Biocaptiva Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.